BioDlink updates capital structure and disclosure duties amid Wuxi Biologics offer

The latest announcement is out from TOT BIOPHARM International Co. Ltd. ( (HK:1875) ).

BioDlink International Company Limited has updated the market on changes to its capital structure during an ongoing takeover offer involving Wuxi Biologics, confirming that 142,000 share options vested on 1 March 2026 and providing an updated count of its issued shares, restricted share awards and outstanding options. The company also reminded associates of both the offeror and offeree, including major holders of relevant securities, of their disclosure obligations under Hong Kong’s Takeovers Code during the offer period and cautioned shareholders and option holders that completion of the offers remains conditional and may not proceed.

The revised tally shows 772,787,887 shares outstanding, including vested and unvested restricted share awards, and 7,632,600 share options, most of which are vested but unexercised, with no other relevant securities outstanding under the code’s definition. Regulators’ disclosure rules were emphasised, with intermediaries such as brokers and banks urged to ensure clients comply with reporting requirements, while investors were advised to review the composite offer document and independent advice before deciding whether to accept the pending offers, reflecting ongoing uncertainty around deal completion.

The most recent analyst rating on (HK:1875) stock is a Hold with a HK$4.50 price target. To see the full list of analyst forecasts on TOT BIOPHARM International Co. Ltd. stock, see the HK:1875 Stock Forecast page.

More about TOT BIOPHARM International Co. Ltd.

BioDlink International Company Limited, listed in Hong Kong under stock code 1875, operates in the biopharmaceutical sector. The company is involved in developing and commercialising biologic therapies, and its securities structure includes ordinary shares, restricted share awards and share options held by employees and other stakeholders.

Average Trading Volume: 3,510,641

Technical Sentiment Signal: Buy

Current Market Cap: HK$3.17B

For an in-depth examination of 1875 stock, go to TipRanks’ Overview page.